PerkinElmer Inc. logo

PerkinElmer Inc.

PKI | NYSE
Chart Builder DCF Calculator
$115.24
$0.00 (0.00%)
Nov 2, 2026, 12:49 PM ET · Market open

Company Profile

PerkinElmer, Inc. operates as a global enterprise delivering innovative products, specialized services, and comprehensive solutions across the diagnostics, life sciences, and applied technology sectors. The company's operations are divided into two main segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions division furnishes scientists with an extensive suite of offerings, including chemical reagents, informatics platforms, and cutting-edge detection and imaging technologies. These resources are designed to accelerate research breakthroughs in the life sciences, and the segment also provides contract research and laboratory services. Additionally, it supplies analytical technologies, integrated solutions, and expert services to clients in the environmental, food, and industrial markets, aiding in the assessment and characterization of air, water, and soil quality. This segment further supports agricultural producers and food manufacturers, and delivers analytical instrumentation to a broad spectrum of industrial clients, encompassing chemical, semiconductor, electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment specializes in providing essential instruments, reagents, assay platforms, and software products for the early identification of genetic disorders, particularly during pregnancy and early childhood, as well as for infectious disease screening. Its product range facilitates the testing and detection of various genetic abnormalities and conditions, such as Down syndrome, hypothyroidism, muscular dystrophy, infertility, and diverse metabolic disorders. Moreover, this segment develops enabling technologies that support advanced genomic workflows, leveraging methods like G-protein coupled receptor (GPCR) analysis and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery research. PerkinElmer's client base is diverse, including pharmaceutical and biotechnology companies, research laboratories, academic and scientific institutions, public health organizations, private healthcare providers, medical professionals, and governmental agencies. Founded in 1937, PerkinElmer, Inc. is headquartered in Waltham, Massachusetts.

Key Executives

Name Position
Prahlad R. Singh Chief Executive Officer, Pres & Director
Maxwell Krakowiak Senior Vice President & Chief Financial Officer
Andrew Okun Vice President, Chief Accounting Officer & Treasurer
Daniel R. Tereau Senior Vice President of Strategy & Bus. Devel.
Joel S. Goldberg Senior Vice President of Admin., Gen. Counsel & Sec.
Masoud Toloue Senior Vice President of Diagnostics
Miriame Victor Senior Vice President & Chief Commercial Officer
Robert Francis Friel Advisor
Stephen Barr Willoughby Senior Vice President of Investor Relations & Head of ESG
Tajinder Vohra Senior Vice President of Global Operations

Latest SEC Filings

Date Type Title
Oct 02, 2026 4 Filing
Sep 23, 2026 4 Filing
Sep 18, 2026 4 Filing
Sep 08, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 25, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 17, 2026 4 Filing
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 11, 2026 10-Q Quarterly Report
View All SEC Filings ➞
PerkinElmer Inc.
PerkinElmer Inc. logo
Country United States
IPO Date Apr 6, 1983
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 16,700
CEO Prahlad R. Singh

Contact Details

940 Winter Street Waltham, Massachusetts 02451 United States

Stock Details

Ticker Symbol PKI
Exchange NYSE
Fiscal Year February - January
Reporting Currency USD
CIK Code 0000031791
CUSIP Number 714046109
ISIN Number US7140461093
SIC Code 3826

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.